HAVN — HAVN Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapSucker Stock
- CA$0.80m
- CA$0.81m
- CA$0.28m
Annual cashflow statement for HAVN Life Sciences, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.041 | -30.4 | -22.4 |
| Depreciation | |||
| Non-Cash Items | -0.001 | 16 | 14.5 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.034 | -0.615 | -0.536 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -0.075 | -10.4 | -7.88 |
| Capital Expenditures | — | -0.033 | -0.103 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -0.25 | -0.364 | -1.93 |
| Acquisition of Business | |||
| Sale of Fixed Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0.25 | -0.397 | -2.03 |
| Financing Cash Flow Items | 0.02 | -1.16 | -0.335 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.94 | 18.6 | 1.56 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 1.62 | 7.78 | -8.35 |